What is the CVR number of Y-mAbs Therapeutics A/S?

Y-mAbs Therapeutics A/S is registered with CVR / Virk under CVR 37053678.

What is the revenue of Y-mAbs Therapeutics A/S?

Y-mAbs Therapeutics A/S reported revenue of 29,3 mio. kr. in 2025.

Y-mAbs Therapeutics A/S employs 16 people as of the latest annual report.

Vincent Sainte-Catherine is the CEO of Y-mAbs Therapeutics A/S, in role since 2025.

Antoine Bernasconi chairs the board of Y-mAbs Therapeutics A/S, in role since 2025.

Y-mAbs Therapeutics A/S's registered address is Agern Alle 13.

A/SActiveAdvertising protection

Actively employed in the business

Name	Role	Member since
Current (1)
VS Vincent Sainte-Catherine Chief Executive Officer	Chief Executive Officer	2025

Former (3)


TG Thomas Gad Chief Executive Officer	Chief Executive Officer	2022 – 2023
CJ Claus Juan Møller-San Pedro Management	Management	2015 – 2022
MJ Michael Joseph Rossi Chief Executive Officer	Chief Executive Officer	2023 – 2025

Non-executive oversight

Name	Role	Member since
Current (3)
JF Julien Forest Board of Directors	Board of Directors	2025
AB Antoine Bernasconi Chairman	Chairman	2025
VS Vincent Sainte-Catherine Board of Directors	Board of Directors	2025

Former (13)


DN David Neil Gill Board of Directors	Board of Directors	2018 – 2021
TG Thomas Gad Chairman	Chairman	2024 – 2025
BK Bo Kruse Chairman

As of last annual report

Shareholder	Type	Ownership	Votes	Since
Y-mAbs Therapeutics, Inc.	Company	100%	100%	2015

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.